LifeMD announces plans to expand affordable access to Wegovy

LifeMD (LFMD) announced plans to offer broad, affordable, and streamlined access to Wegovy through NovoCare Pharmacy. This integration offers a simplified pathway for cash-pay patients to access all FDA-approved dose strengths of Wegovy directly within LifeMD’s virtual care platform. LifeMD’s weight management program is one of the fastest-growing cash-pay offerings in the country, delivering virtual consultations, lab testing, diet and lifestyle support, and prescriptions to anti-obesity medications including GLP-1s when clinically appropriate, within a single, tech-enabled platform. The addition of direct access to Wegovy through NovoCare Pharmacy enhances LifeMD’s ability to support patients with a brand-name GLP-1 option at a recently reduced self-pay cost of $499 per month, including convenient home delivery.